Pharsight Launches PKS Online™, Bringing Benefits of Leading PK Data Management Solution to Customers On-Demand

ST. LOUIS–(BUSINESS WIRE)–Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced the launch of PKS Online™. PKS Online is an Internet-accessible implementation of Pharsight Knowledgebase Server™ (PKS™), the company’s enterprise data management system for secure storage and tracking of PK/PD data and analyses, that lets customers realize the benefits of a compliant PK repository without upfront capital expenditure.

“PKS Online offers the full benefits and value of PKS to drug development organizations with limited staff and resources for deployment, validation and management of an in-house system,” said Daniel Weiner, Ph.D., senior vice president and chief technology officer of Pharsight. “PKS Online provides secure storage, access and tracking for PK/PD data, analyses and related files, all of which are accessible over the Internet from networked desktops. Like PKS, PKS Online remains fully integrated with Phoenix™ WinNonlin®, Phoenix Connect™ and earlier versions of WinNonlin®, as well as Pharsight’s software tools for PK analysis automation and reporting. The result is improved productivity and compliance for PK scientists, data managers, quality assurance experts and their company’s external development partners and collaborators.”

PKS Online is offered on a subscription basis, with flexible licensing and value-added validation support services. Pharsight has engaged with Savvis, a global leader in outsourced internet infrastructure services for the enterprise, to deliver PKS Online.

“The release of PKS Online demonstrates Pharsight’s ongoing commitment to providing our customers with access to software solutions that enable model-based drug development and its utility in translational science,” added Dr. Weiner. “With PKS Online, we are extremely pleased to deliver the benefits of PKS to a wider range of pharmaceutical and biotechnology industry customers through a software-as-a-service model, and look forward to moving them into production quickly and reliably to meet their drug development objectives.”

About PKS Online™

PKS Online is an Internet-accessible implementation of Pharsight Knowledgebase Server™ (PKS), the company’s enterprise data management system for secure storage and tracking of PK/PD data and analyses. Pharsight has engaged with a leading hosting provider to bring the benefits of PKS to scientist’s desktops on-demand. Using a standard desktop computer and a standard network connection, PK scientists, data managers, review staff and a sponsor’s external development partners can access PKS Online through a secure channel from virtually anywhere and at anytime. Pharsight believes that the availability of a comprehensive and accessible PK/PD research data management system will provide a foundation for a more rational and cost-effective drug development process, by improving scientific productivity and compliance and dramatically reducing IT overhead. More information about PKS Online is available at www.pharsight.com.

About Pharsight

Pharsight, a Certara™ company, is a market-leading provider of software products and scientific consulting services to help pharmaceutical and biotechnology companies improve their drug development process, regulatory compliance and strategic decision-making. Established in 1995, the company’s goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products. Pharsight leverages expertise in its software tools and in the disciplines of pharmacology, drug and disease modeling, human genetics, biostatistics, strategic decision-making and regulatory strategy. Headquartered in St. Louis, Missouri, with more than 1200 customers worldwide, Pharsight products and services are used by all of the world’s top 50 pharmaceutical firms.

About Certara

Certara is dedicated to improving human health through a broad spectrum of products and services, from molecular discovery to clinical research. Formed in 2008, Certara unites Tripos and Pharsight Corporation. Tripos is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Pharsight is the leading provider of software and scientific services to improve productivity and decision-making in clinical drug development. Certara expects to provide its clients with important new products, key enabling technologies and scientific expertise to expedite the flow of information throughout drug discovery and development. Certara is focused on reducing the barriers between the phases of research that will speed discoveries in chemistry and enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products.

Registered Trademarks and Trademarks

Pharsight, PKS Online, Pharsight Knowledgebase Server, PKS, Phoenix WinNonlin, Phoenix Connect and WinNonlin are trademarks or registered trademarks of Tripos, L.P. All other brands and product names are trademarks or registered trademarks of their respective holders.